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It has been known for a number of years that lymphoblastoid cells established 
in continuous culture will stimulate the proliferation of lymphocytes from the 
donor from whom the  cell  line  was  derived  (1-2).  This  observation has  been 
interpreted  as  reflecting  the  expression  of  viral  antigens,  blast-associated 
antigens,  derepressed genetic material,  or new HLA specificities on lymphoid 
cells in continuous culture.  However, the recent demonstration that purified B 
lymphocytes stimulate  autologous  T-lymphocyte proliferation  (3,  4)  suggests 
that  the  stimulatory  capacity of autologous  lymphoid  cells  depends  on their 
lineage and not on their establishment in continuous culture.  For this reason, 
we have reevaluated the capacity of B-lymphoid cell lines and purified B cells 
to  stimulate  the  proliferation  of autologous  T  lymphocytes  and  to  generate 
cytotoxic T lymphocytes. 
Materials  and Methods 
Lymphoid Cell Lines (LCL).  LCL were initiated and maintained as previously described (5). 
Briefly,  mononuclear cells in RPMI  1640  with 20% fetal bovine serum  (FBS) were mixed with 
supernate  from  the  EBV  producing  cell  line B95-8,  and were  incubated at  37°C.  Half of the 
medium was replaced each week,  and with establishment of the LCL stationary cultures at a 
density  of 5-10  ×  105  cells/ml  were  maintained.  Three  autologous  lymphoid  cell  lines  were 
established from individuals whose peripheral blood lymphocytes were available for continuous 
testing. These were Lig, Letch, and Hoff. All of these grew well in continuous culture and were 
utilized several years after initial establishment. 
HLA Typing of LCL and Peripheral Blood Lymphocytes  (PBL).  HLA typing of PBL and LCL 
were  kindly  performed  by  Dr.  M.  Fotino  at  the  New  York  Blood  Center,  by  a  two-stage 
microcytotexicity technique. Cell lines present special problems in HLA typing because of their 
B-cell alloantigens. Specificities listed represent those also present on autologous PBL; any extra 
reactions encountered are not included. The apparent HLA specificities of the cells used in these 
experiments  were  as  follows:  Lig  A1,A2,B8,B12;  Leteh  A1,A2,B7,B8;  Hoff A2,B12,B13;  4265 
A2,AW32,B7,B12;  8392  A1,A10,B7,BW17;  B35M  A1,A3,B7,B8;  CMS  A9,AW24,B7,BW15;  AG 
A1,A2,B12,BW17;  RV  A2,B12,BW18;  and  JH  A1,All,BW5.  Typing  for  B-cell  antigens  was 
kindly performed by Dr.  R.  Winchester and Dr.  A.  Gibofsky (6).  Results with sera previously 
found to be correlated with HLA-D typing by mixed lymphocyte culture (MLC) allowed tentative 
assignment of the following DW associated specificities: Lig 1,3;  Letch 3,-; Hoff 3,3 or 3,4; 4265 
1,4; and B35M 3,3. 
Purification  of B  Cells  and  T  Cells.  After initial separation on Ficoll-Hypaque  gradients, 
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lymphocytes were fractionated by using E-rosette separation techniques. The nonrosetting layer 
was composed primarily of Ig-bearing cells and monocytes. The percent of T-cell contamination 
determined by  re-rosetting ranged  from  2  to  15%. The  rosetting population was  of uniform 
lymphocyte morphology and was 90-98%  pure T cells by re-rosetting. 
Preparation of MLC.  The micromethod used was a modification of the technique described by 
Hartzman  et  al.  (7).  Unidirectional MLCs  were  established in  triplicate,  each  culture  well 
consisting of 0.2 ml of culture medium containing 1 x  105 responding lymphocytes and either 1 x 
l0  s irradiated (3,000 rads) stimulating lymphocytes or 3 x  104 irradiated (6,000 rads) stimulating 
LCL cells. Primary cultures were incubated for 144 h  at 37°C in a humidified COs environment. 
Cultures were pulsed with [3H]thymidine, harvested, and assayed for thymidine incorporation as 
previously described (4). Cells were used as cell-mediated lympholysis (CML) effectors or primed 
responder cells in secondary MLC  after culture in small flasks. Cultures consisted of 20 ml of 
medium containing 1 x  107 responder cells and either 1 x  107 stimulating lymphocytes or 3 x  106 
stimulating LCL cells. Cultures for generation of CML effector cells were stopped after 6 days, 
except for  autologous  purified  B-cell stimulation,  when  cultures  were  incubated for  7  days. 
Secondary cultures were established after lymphocytes had been incubated for 10 days. 
In  third party  cell experiments, heat treatment of PBL  was  done  at  45°C for  90  rain  (8). 
Viability was greater than 90% after treatment. The number of viable heat-treated cells added to 
a culture was equal to the number of responder cells. 
Peripheral blood lymphocytes to be used as CML target cells were incubated at 1 x  106 cells/ 
ml in standard culture medium without mitogen, for 6 or 7 days. 
CML Assay.  A  modification of the standard radioactive chromium (5~Cr) release assay (9) 
was used. Cultured PBL and LCL to be used as target cells were washed and incubated with an 
equal volume of 5~Cr-labeled sodium chromate; followed by washing, resuspension in medium, 
and kept at 4°C. Effector cells were harvested from MLC flasks, washed three times in PBS, and 
resuspended in  RPMI  1640 with  20%  FBS.  Assay  was  performed in  triplicate  in  V-bottom 
microtiter plates, each well containing 0.1 ml of target cell suspension and 0.1 ml of effector cell 
suspension.  Target  cells  without  effector cells  were  mixed  with  0.1  ml  medium  to  obtain 
spontaneous 51Cr-release, and with 0.1 ml detergent to obtain maximal 5~Cr-release. 
After addition of cells, plates were spun at 40 g  for 5 min, then incubated for 4 h  at 37°C in a 
humidified 5% CO2 environment. After incubation, plates were spun at 200 g  for 10 min at 4°C. 
0.1  ml  of supernate was carefully removed from each well  and  counted in  a  Packard  Auto- 
Gamma scintillation counter (model no. 5385, Packard Instrument Co., Inc., Downers Grove, Ill.). 
The percentage of specific lysis was calculated for each effector to target cell ratio tested as 
described previously  (9).  The percent CML  values obtained in triplicate determinations  were 
plotted versus the logz~  of  the effector  to target cell  ratio.  A  dose-response curve was obtained by 
using points from the four effector  to target cell  ratios tested in each case. A lytic  unit (LU) was 
arbitrarily defined as that number of  effector  cells  required to yield 30% lysis. 
Results 
Lymphocyte  Proliferation  Stimulated  by  Autologous  LCL  or  Purified  B 
Cells.  Lymphocyte  proliferation  is  markedly  stimulated  by  autologous  or 
allogeneic  LCL.  This was documented not only by the increased incorporation 
of [aH]thymidine  but also  by the  three  to  fivefold  increase  in the  number of 
lymphocytes present at the end of the culture period. Allogeneic and autologous 
LCL stimulated lymphocyte proliferation to a s~milar degree.  Maximal thymi- 
dine incorporation occurred after 5 or 6 days of culture for both allogeneic  and 
autologous LCL stimulation. 
Thymidine  incorporation  at  the  peak  of  the  autologous  and  allogeneic 
response was  always  greater  with  LCL  stimulators  than  with  purified  B-cell 
stimulators  from the cell  line  donors.  Kinetic  studies by  Weksler  and  Kozak 
(10) have shown that the peak response to allogeneic purified B  cells occurs on 
day 5 or 6 while the peak response to autologous purified B cells occurs on day 
6 or 7. Similar results were obtained in the present study. VANDE  STOUWE  ET  AL.  BRIEF  DEFINITIVE  REPORT  1811 
TABLE  I 
MLC with Autologous LCL and Purified B-Cell Stimulators: Cytotoxic Cell Generation 
MLC Combination 
Lig + Lig LCLx 
CD + Lig LCLx 
Letch T + Bx 
MLC Combination 
Letch T  +  Bx 
Lig +  Lig LCLx 
l_etch  +  Letch LCLx 
Hoff +  Hoff LCLx 
Letch +  Lig LCLx 
3H,  cpm 
77,380  -+ 6,270 
69,040  "+ 470 
19,950  "+ 1,980 
SH, cpm 
19,950  "+ 1,980 
62,800  "+ 3,700 
47,280  -+ 8,040 
58,200  ±  3,300 
64,080  -+ 19,100 
X =  Stimulator  cells X irradiated. 
% CML against PBL target cells 
1 
1 
1 
% CML against LCL target cells 
Letch  Lig 
23-+4118±3 
32"+4131"+6 
29"+1123"+3 
Hoff 
-1-+2 I 1±2 
37±2[24±4 
35"-5124"+3 
23++1118"+2 
4265 
-2+1  I  2+-0 
34-+3126-+9 
48"-4139"-1 
34±4129"-2 
8392 
±2 
±2 
±2 
±1 
±3 
Secondary responses  (maximal  on day 3) could be stimulated by autologous 
LCL after primary stimulation by B cells. The reverse experiment with primary 
stimulation  by  LCL  and  secondary  B-cell  challenge  gave  similar  effects. 
Allogeneic  cells  also  gave  an  accelerated  secondary  response  after  primary 
stimulation  with  either  autologous  LCL  or  B  cells,  although  the  degree  of 
stimulation was less than with the secondary autologous additions. 
Cytotoxic  T-Cell  Generation.  No  cytotoxic  T  cells  were  detectable  after 
stimulation  with  autologous  purified  B  cells  or  autologous  B-lymphoid  cell 
lines  when  peripheral  blood target  cells  were  used.  Numerous  experiments 
showed this  was  always the  case.  Representative  experiments  are  shown  in 
Table  I.  In  10  experiments,  mean  peak  thymidine  incorporation  by T  cells 
cultured with purified autologous B cells (19,409  +_ 5,651 cpm) was significantly 
greater than the sum of the thymidine incorporated by T  cells alone  (1,143  _+ 
867 cpm) and irradiated B cells alone (1,039 _+ 551 cpm).  Despite this prolifera- 
tive response,  no cytotoxicity was developed against  autologous or allogeneic 
LCL or PBL.  In contrast the allogeneic MLC always developed specific CML 
towards PBL or LCL bearing the stimulating  alloantigens. 
Similar results were found when autologous LCL were used as stimulators. 
Thus,  despite  the  extremely  high  thymidine  incorporation  by  lymphocytes 
cultured with autologous LCL no cytotoxicity was observed against PBL from 
the donor of the stimulating  LCL or against any other peripheral  blood cells. 
When lymphoid cell lines were used as target  cells,  some nonspecific killing 
was  observed  when  LCL  were  also  used  to  stimulate  autologous  T  cells. 
However the cytotoxicity against the LCL used as stimulator was always less 
than  the  cytotoxicity against  heterologous  LCLs  (Table I).  This  was  not the 
case when autologous B cells were used as stimulators;  no killing above base- 
line values was observed against LCL targets. 
The  nonspecific  cytotoxicity generated  in  the  autologous  LCL culture  was 
considerably below the cytotoxicity generated  in  the  allogeneic LCL culture. 
This was particularly evident when the results were calculated as LU  per 10  3 1812  VANDE  STOUWE  ET  AL.  BRIEF  DEFINITIVE  REPORT 
cells. After culture with autologous LCL, the LU generated were less than 2 when 
stimulating LCL used as targets and 13-143 when heterologous LCL were used 
as targets. After culture with allogeneic LCL, the specific LU generated ranged 
from 830 to 10,000  when the stimulating LCL was used as target. 
Cytotoxic  Cell  Generation  in  Third Party Systems.  The  autologous  MLC 
with purified B-cell stimulators or LCL is a  proliferative response without the 
generation of significant cytotoxic T cells. Experiments were performed to deter- 
mine  if the  autologous  MLC  would provide  a  proliferative  stimulus  for  CTL 
generation in the presence of nonstimulating third party cells with foreign HLA 
antigens.  Heat-treated lymphocytes possess HLA-A and  HLA-B determinants, 
but neither stimulate the MLC nor by themselves generate cytotoxic lymphocytes 
(CTL) (8). A variety of experiments with different cell combinations in autologous 
MLC with purified B-cell stimulators were performed in the presence and absence 
of allogeneic heat-treated cells. As had been previously reported, heat treatment 
completely abolished the capacity of B cells to stimulate proliferation of T  cells 
and the generation of cytotoxic T cells. However, the addition of these cells to the 
autologous  MLC  reactions  in  each  case  resulted  in  the  generation  of specific 
CTL's directed against  target  cells bearing the  HLA determinants  of the heat 
treated cell used.  No cytotoxicity to autologous cells was found.  Similar results 
were obtained with the autologous LCL system. In Table II, two representative 
experiments are shown. The pattern of cytotoxicity in the autologous MLC plus 
heat-treated allogeneic cell combination was identical to the standard allogeneic 
MLC control. 
Discussion 
In the present study long-term lymphoid cell lines were obtained from three 
individuals  who were available  for continued  studies  of the  autologous MLC 
reaction.  This  permitted  the  stimulatory  capacity  of B-lymphoblastoid  line 
cells and purified B cells from peripheral blood from the same individual to be 
compared  in  autologous  MLC  reactions.  Both  systems  have  been  studied 
independently,  lymphoid cell lines a  number of years ago (1,  2) and normal B 
cells  more  recently  (3,  4).  The  latter  studies  suggest  that  the  earlier  LCL 
autologous stimulation studies may have been misinterpreted and that the two 
systems are analogous. The present work centered on the production of cytotoxic 
cells in these autologous systems. No cytotoxic cells were generated during the 
autologous  MLC  when  purified  B  cells  were used  as  autologous  stimulators 
regardless of whether peripheral  blood cells or cell lines  were used as target 
cells. 
No specific cytotoxic cells were detected when autologous LCL were used as 
stimulators in the autologous MLC although some general cytotoxicity against 
a  variety  of cell  lines  was  observed.  The  level  of cytotoxicity  was  low  in 
comparison with the level of specific cytotoxic reactivity stimulated by alloge- 
neic LCL. It also was evident that cytotoxicity generated was nonspecific as it 
was lower against  the  stimulating  LCL than  against  heterologous lines.  The 
exact cause of this cytotoxicity remains  unclear.  It is known and was evident 
in  the  present  study  that  certain  cell  lines  are  very  susceptible  to  lysis  as 
target  cells.  This  may have  been one  factor in the  cytotoxicity observed but 
certainly  not  the  only  factor  in  view  of the  lower  cytotoxicity against  the VANDE  STOUWE  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE II 
Generation of Specific CTL by Corf~bination of an Autologous  MLC 
and Heat-Treated Allogeneic Lymphocytes 
1813 
MLC Combination  ~H Uptake, cpm 
% CML 
PBL Target8 
Letch  Hoff  CMS 
100:1  25:1  100:1  25:1  100:I  25:1 
Letch T  290  -+  140  -3  -+  2  -3  ±  i  0  ±  1  -1  ±  1  -1  ±  0  -1  ±  0 
Letch T  +  Bx  29,230  ±  2,600  -5  ±  2  -3  ±  0  -1  ±  0  -1  ±  2  -1  -+  1  -2  ±  0 
Letch T  +  A Hoff PBL  1,620±420  -9±2  -7±1  -6~-1  -1-+1  -6±2  -6+-1 
Letch T  +  Bx +  A HoffPBL  18,800  ±  660  -14-+1  -10±2  29-+2  23±3  -8±1  -5_+3 
Leteh T  +  Hoff PBL  x  36,680±2,390  -4-+3  -1±2  37±2  28_-1  2±1  0±1 
CMST  129_+65  -4±1  -4±2  2-+1  1±1  -1-+1  1±1 
CMS T  +  I~  19,170  -+  1,180  -6  ±  2  -2  ±  1  -3  ±  1  -3  -+  2  -2  ±  0  -1  ±  3 
CMS T  +  A Leteh PBL  173  _*  39  -8  ±  2  NT  -4  ±  1  NT  -5  ±  2  NT 
CMST  + Bx + hLetchPBL  20,666 ± 1,650  41-+4  25±2  28±I  22±2  -I±i  -4±0 
CMS T  +  Leteh PBLx  28,574  ±  3,073  36 ±  3  20 --  2  32 ±  3  21  -+  1  2  -+  2  0  -+  1 
* NT =  not tested. 
stimulating  line.  The latter finding also argues against  a  role for cytotoxicity 
against EB viral antigens in the cell lines.  However, this is not ruled out and 
studies are underway to answer this question. 
The  results  of experiments  involving  heat-treated  third-part  cells  indicate 
clearly the  distinction  between the  proliferative  and  cytotoxic phases  of the 
MLC  response.  More  importantly  they  show  that  the  interaction  between 
unmodified autologous cell populations in collaborating with a foreign antigenic 
determinant  can  generate  cytotoxic reactivity which  cannot be generated  by 
the foreign determinant  itself.  This  raises the possibility that  the autologous 
MLC may be of significance in vivo. Cells bearing foreign antigens  may exist 
in  vivo as a  consequence of viral  infection or neoplastic transformation.  The 
autologous  MLC  in  localized  areas  may  provide  the  proliferative  stimulus 
needed for the generation  of CTL in vivo against such cells.  Recently several 
groups  (11,  12)  have  found that  lymphocytes from  some  normal  individuals 
sensitized  to  MHC  identical  leukemia  cells  could,  in  the  presence  of  an 
allogeneic  proliferative  stimulus,  differentiate  into  specific CTL  against  the 
leukemia cells. The autologous MLC proliferative stimulus might also be used 
to create in vitro specific cytotoxic cells against specific neoplasms without the 
introduction of allogeneic cells. 
Summary 
Autologous mixed lymphocyte culture (MLC) reactions were studied utilizing 
autologous purified B cells and autologous established B lymphoid cell lines as 
stimulating  cells.  Similar  results  were obtained  although  somewhat  greater 
stimulation of lymphocyte proliferation was found with the autologous lymphoid 
cell lines.  Cytotoxic T cells were not generated against the stimulating cells in 
either case when peripheral blood cells were used as targets. A low cytotoxicity 
was  detected  when  lymphoid  cell  lines  were  used  both  as  stimulators  and 
target cells. However this was nonspecific and was always greater for heterolo- 
gous lines than for the stimulator line. 1814  VANDE  STOUWE  ET  AL.  BRIEF  DEFINITIVE  REPORT 
Third-party  cell  experiments  demonstrated  that  the  autologous  reaction 
could serve as a proliferative stimulus for specific cytotoxic lymphocyte genera- 
tion. Heat-treated allogeneic lymphocytes that alone do not stimulate prolifer- 
ation  or  cytotoxic  T-cell  generation  in  MLC  reactions  when  added  to  the 
autologous  system  produced  specific  cytotoxic  cells.  The  separation  of the 
proliferative phase from the cytotoxic cell generation was especially striking in 
these  experiments.  Possible  uses of this  system for the  generation of specific 
cytotoxic cells to other nonstimulatory cells are discussed. 
Received for publication 28 September 1977. 
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